↓ Skip to main content

Intubating conditions and side effects of propofol, remifentanil and sevoflurane compared with propofol, remifentanil and rocuronium: a randomised, prospective, clinical trial

Overview of attention for article published in BMC Anesthesiology, May 2014
Altmetric Badge

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intubating conditions and side effects of propofol, remifentanil and sevoflurane compared with propofol, remifentanil and rocuronium: a randomised, prospective, clinical trial
Published in
BMC Anesthesiology, May 2014
DOI 10.1186/1471-2253-14-39
Pubmed ID
Authors

Thomas Mencke, Refa Maria Jacobs, Susann Machmueller, Martin Sauer, Christine Heidecke, Anja Kallert, Hans Wilhelm Pau, Gabriele Noeldge-Schomburg, Attila Ovari

Abstract

Tracheal intubation without muscle relaxants is usually performed with remifentanil and propofol or sevoflurane. Remifentanil 1.0 to 4.0 μg·kg(-1) and propofol 2.0-3.0 mg·kg(-1) or sevoflurane up to 8.0 Vol% provide acceptable, i.e. excellent or good intubating conditions. We hypothesized that sevoflurane 1.0 MAC would provide acceptable intubating conditions when combined with propofol and remifentanil.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 1%
Unknown 69 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 13%
Other 7 10%
Researcher 7 10%
Student > Doctoral Student 6 9%
Professor > Associate Professor 4 6%
Other 17 24%
Unknown 20 29%
Readers by discipline Count As %
Medicine and Dentistry 31 44%
Nursing and Health Professions 6 9%
Biochemistry, Genetics and Molecular Biology 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Unspecified 2 3%
Other 6 9%
Unknown 21 30%